SRSF1和SRSF2协同调节Bim表达,以调节骨质母细胞中葡萄糖皮质激素诱导的亡
Hong Luo1, Jian Zhang2, Fei Zhang2
1Department of Orthopedics and Emergency, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, 550004, China; Department of Orthopedics, The Affiliated Wudang Hospital of Guizhou Medical University, Guiyang, Guizhou, 550018, China.
葡萄皮质类药物通过降低分离因子SRSF1和SRSF2.2的调节来诱导骨质细胞亡. 抑制这些因素可以预防类固醇诱导的骨疾病,如SONFH和骨质疏松症.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 葡萄糖皮质体 (GC) 诱导的骨质细胞 (OB) 亡是类固醇诱导的股骨头骨硬化 (SONFH) 和骨质疏松症的关键因素.
- 了解GC诱导的OB亡的调节机制对于开发治疗策略至关重要.
- 拼接因子在细胞过程中发挥作用,但它们参与GC诱导的OB亡需要阐明.
研究的目的:
- 为了研究拼接因子SRSF1和SRSF2在葡萄糖皮质激素诱导的骨质细胞亡中的作用和机制.
- 探索SRSF1和SRSF2作为类固醇诱导骨疾病的治疗点的潜力.
主要方法:
- 转录组测序和生物信息学分析,以确定GC治疗的OB中差异表达的基因.
- RNA免疫沉和RNA拉下测试以确认SRSF1和SRSF2.2之间的相互作用.
- 过度表达和敲击实验,以评估SRSF1和SRSF2对GC诱导的OB亡的功能影响.
主要成果:
- 在GC治疗的OB中,SRSF1和SRSF2的表达显著下调,与亡相关.
- SRSF1和SRSF2直接相互影响.
- 过度表达SRSF1或SRSF2抑制了GC诱导的OB亡,而它们的淘汰会加剧它.
- GC治疗抑制了SRSF1/SRSF2的表达,导致Bim的协同上调,caspase-9/caspase-3的激活,最终导致OB的亡.
结论:
- SRSF1和SRSF2对GC诱导的OB亡起着保护作用.
- 该机制涉及Bim表达和酶激活的协同调节.
- SRSF1和SRSF2代表了预防和治疗SONFH和类固醇诱导的骨质疏松症的潜在治疗点.
更多相关视频
07:51Effect of Anti-c-fms Antibody on Osteoclast Formation and Proliferation of Osteoclast Precursor In Vitro
Published on: March 18, 2019
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
相关概念视频
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Osteoclasts in Bone Remodeling
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of Hematopoietic Stem Cells
